S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
pixel
pixel
pixel
S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
pixel
pixel
pixel
S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
pixel
pixel
pixel
S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
pixel
pixel
pixel
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 OtonomyRockwell MedicalZynerba PharmaceuticalsAileron TherapeuticsSio Gene Therapies
SymbolNASDAQ:OTICNASDAQ:RMTINASDAQ:ZYNENASDAQ:ALRNNASDAQ:SIOX
Price Information
Current Price$2.90$1.43$4.68$1.54$2.68
52 Week RangeBuyBuyBuyBuyBuy
MarketRank™
Overall Score1.71.31.31.71.2
Analysis Score3.53.53.43.53.3
Community Score2.62.42.72.62.7
Dividend Score0.00.00.00.00.0
Ownership Score1.70.00.01.70.0
Earnings & Valuation Score0.60.60.60.60.0
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$8.10$5.50$15.40$3.50$13.63
% Upside from Price Target179.31% upside284.62% upside229.06% upside127.27% upside408.40% upside
Trade Information
Market Cap$140.13 million$133.81 million$137.78 million$128.76 million$126.63 million
Beta2.311.112.833.13N/A
Average Volume1,379,4042,329,4067,361,5895,737,1561,840,974
Sales & Book Value
Annual Revenue$600,000.00$61.30 million$90,000.00N/AN/A
Price / Sales233.542.181,530.83N/AN/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$1.31 per share$0.32 per share$3.26 per share$0.58 per share$1.67 per share
Price / Book2.214.471.44N/AN/A
Profitability
Net Income$-44,670,000.00$-34,130,000.00$-32,940,000.00$-29,370,000.00$-72,630,000.00
EPS($1.45)($0.56)($1.50)($1.20)($2.93)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-14,379.87%-47.23%N/AN/AN/A
Return on Equity (ROE)-108.75%-117.67%-60.20%-170.37%-101.13%
Return on Assets (ROA)-54.62%-46.33%-52.40%-98.29%-68.72%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.20%0.50%N/A0.03%N/A
Current Ratio8.97%6.13%6.54%3.04%7.00%
Quick Ratio8.97%5.83%6.54%3.04%7.00%
Ownership Information
Institutional Ownership Percentage72.25%26.72%25.99%6.67%24.12%
Insider Ownership Percentage16.10%4.70%11.10%6.20%4.20%
Miscellaneous
Employees56299281338
Shares Outstanding48.32 million93.57 million29.44 million83.61 million47.25 million
Next Earnings Date5/6/2021 (Estimated)3/11/2021 (Estimated)3/9/2021 (Estimated)3/29/2021 (Estimated)6/9/2021 (Estimated)
OptionableOptionableOptionableOptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.